Close this search box.
Close this search box.

Prostate cancer


Prostate cancer is the most common cancer affecting men in the western world. Approximately 30% of all newly diagnosed cases of cancer in men are prostate cancer. In Cyprus, there are approximately 800 new cases of prostate cancer each year. The main risk factors for prostate cancer are age, family history and race, with Black people having a greater risk of developing prostate cancer.


Early prostate cancer has no clear symptoms, so most prostate cancer cases are detected through elevated prostate-specific antigen (PSA) levels found through a blood test. If you have elevated PSA levels, your doctor will most likely recommend you undergo a stereotactic biopsy at the GMI Prostate Cancer Center. This involves a tissue sample being taken and examined under a microscope. The results of the biopsy will confirm the diagnosis and give your doctors more information on the cellular and molecular characteristics of the tumor. The Gleason grading system and the International Society of Urological Pathology (ISUP) grading system, are used to determine the characteristics of the tumor and to guide therapy. 

Additionally, the GMI team may recommend you undergo dedicated molecular marker testing, such as the genomic classifier Decipher or the BRCA status, if they deem this is warranted. 

To assess the potential spread of the cancer, your GMI medical team may recommend further imaging. The GMI offers the most advanced medical imaging techniques: multiparametric magnetic resonance imaging (mpMRI), prostate-specific membrane antigen (PSMA), and positron emission tomography / computed tomography (PET / CT).


Every step in the diagnostic procedure helps the GMI team tailor each treatment plan to each patient, taking into consideration your individual case and personal preferences. Your treatment options vary greatly depending on several factors such as the size of the tumor and potential spread of the cancer, how quickly the cancer is progressing and your overall health. To determine the best course of action each patient’s case is discussed in a multidisciplinary tumor board, where several experts from our team come together to create your comprehensive treatment plan. 

For cases where the cancer remains localized, a dedicated team of surgeons or radiation oncologists will eradicate the tumor using the most modern treatment options. The GMI Radiation Oncology team has received world-wide recognition for implementing high-precision radiotherapy techniques, such as brachytherapy or stereotactic body radiotherapy

For cases where the cancer is at a more advanced stage, our Medical Oncology team will propose a treatment plan, which will include the newest regimen of systemic therapies like androgen deprivation therapy, chemotherapy and / or immunotherapy. Additionally, our Department of Nuclear Medicine is one of the first treatment centers in the south-east Mediterranean to offer the PSMA-radioligand therapy, a cutting-edge form of treatment.


At the GMI German Oncology Center, a dedicated team of internationally acclaimed physicians guides each lung cancer patient through their entire journey, from their diagnostic work-up to their treatment and post-treatment care.

The GMI team will never offer a simple “one size fits all” approach to any patient. We believe each patient’s case is as individual as they are and strive to find the best solution for each of our patients, taking their specific case and diagnosis, their lifestyle, and choices into account.

We believe each of our patients is more than their diagnosis. That’s why our dedicated paramedics team supports lung cancer patients on their journey by offering more than just expert medical care. We offer psychological help, integrative oncology services (including yoga classes, and acupuncture) and have a GMI Patient Advocacy Program.

Adhering to our passion for innovation, and desire to progress the medical field, the GMI German Oncology Center both initiates and participates in several clinical trials in which the most modern and advanced treatment concepts are tested.

24-hour Emergency Helpline

(+357) 25 208 000

Emergencies are not yet accredited of the General Health Care System

(+357) 25 208 000

Emergencies are not yet accredited of the General Health Care System.


Dr. Aris Angouridis

About me:

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.